As for its direct effect on psoriasis, it has been reported that the improvement of psoriasis-like skin lesions in a mouse model occurs through the inhibition of the mRNA expression of IL-23 and the activation of dendritic cells via actions on the toll-like receptor 7/8 signaling pathway [228]. The gene discussed is TLR7; the disease is psoriasis.